The above article was sent to subscribers in Pharmacy Daily's issue from 25 Jan 11
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Jan 11
SIGMA Healthcare Limited’s share price has surged this week, reaching $2.06, up from $1.46 seven days ago.
JARDIANCE (empagliflozin) has become the first oral treatment to be available on private script for type 2 diabetes (T2D) in children and adolescents, since metformin was indicated for use in this growing patient group.
PRICELINE is set to undergo a rebrand next month to reflect its strategy combining beauty with health expertise and value.
FREE Pharmacy Daily subscription - never miss another story!
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.